Both Phase 2 and Phase 3 studies point to a clear relationship between dosage and adverse events: lower doses are associated with fewer adverse events
Altogether, the data are kind of messy, said Jennifer Ligibel, an oncologist at Dana-Farber Cancer Institute in Boston
This is why research interpretation should remain balanced
Most importantly, do not discontinue your medication without medical guidance, as symptoms often improve with continued use and appropriate management strategies
We cannot guarantee approval, but clean documentation matters
Figure 7: Photograph of Leonard Thompson in 1930 together with (A) his medical record and (B) chart of his blood sugar levels from December 1921 to January 1922 (credit:Thomas Fisher Rare Book Library, University of Toronto)